Once uploaded, the Israeli-Indian collaboration will enable users make informed decisions in healthcare

DNAtix Ltd, a Blockchain Genetics Company based in Israel, has teamed up with Mapmygenome, a molecular diagnostics company based in India, to change the way people’s personal genome data can be used within the healthcare sector - According to the website Forex Unity News.

DNAtix Ltd provides a direct to consumer (D2C) platform, offering a wide range of genome testing, as well as access to services and solutions using blockchain technology. By partnering with Hyderabad-based molecular diagnostics company Mapmygenome, the blockchain genetics firm will research genetic makeup differently, making anonymity and security a key priority

The DNAtix platform enables anyone to upload partial or full genome sequences anonymously to the platform. Once uploaded, the person gets access to the genetics data so that they can make informed decisions regarding healthcare. Ofer A Lidsky, CEO of DNAtix, says the DNAtix platform will also enable researchers the use of anonymous DNA kept in storage for testing purposes, to conduct research, and formulate new treatments.

Lidsky added: “India is an important market for the use of DNAtix blockchain-based genetic services, based on population numbers alone. Mapmygenome is a major player in the field of genetics and this partnership opens up a tremendous opportunity to help more people really utilize genetic testing and research.”

Mapmygenome, provides a wide range of genetic tests. It is hoped that the partnership between the Indian and Israeli companies will lead to people being able to explore their genetic makeup, without having to compromise on the anonymity and the security of the data.